It is unknown whether Ozempic causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined Ozempic is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Federal Drug Administration (FDA-b)
Los estudios han mostrado una prdida de peso en personas con diabetes, pero este efecto no constituye una indicacin oficial del medicamento
Additionally, individual patient factorsincluding baseline gastric emptying rate, previous gastrointestinal conditions, concomitant medications, and genetic variations in drug metabolismcontribute to the considerable inter-patient variability observed in clinical practice
10.1210/en.2007-1743 Endocrinology 26 HeZ.GaoY.LieuL.AfrinS.CaoJ.MichaelN
GLP-1 receptor agonists Glucagon-like peptide-1 (GLP-1) receptor agonists are used to improve glycaemic control in people with type 2 diabetes